1Gruden G, Thomas SM, Burt D, et al. Mechanical stretch induces VEGF expression in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci USA, 1997, 94: 12112-12116.
2Gruden G, Zonca S, Hayward A, et al. Mechanical stretchinduced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen- activated protein kinase-dependent. Diabetes, 2000, 49:655-661.
3Sharma M, Li JZ, Sharma R, et al. Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro. Nephrol Dial Transplant, 1997, 12: 2064-2068.
4Dr. M.-L. Gross,A. El-Shakmak,A. Szábó,A. Koch,A. Kuhlmann,K. Münter,E. Ritz,K. Amann.ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy[J].Diabetologia.2003(6)
5F. Bonnet,M. E. Cooper,H. Kawachi,T. J. Allen,G Boner,Z. Cao.Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension[J].Diabetologia.2001(7)
6Doublier S,Salvidio G,Lupia E,Ruotsalainen V,Verzola D,Deferrari G,Camussi G.Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II[].Diabetes.2003
7Aaltonen,P,Luimula,P,Astrom,E.Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy[].Laboratory Investigation.2001
8Wu YG,Lin H,Qi XM,Wu GZ,Qian H,Zhao M,Shen JJ,Lin ST.Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes[].International Journal of Immunopharmacology.2006
9Lewis,E.J.,Hunsicker,L.G.,Clarke,W.R.,Berl,T.,Pohl,M.A.,Lewis,J.B.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[].The New England Journal of Medicine.2001
10Anderson S,Rennke HG.Brenner BM: Nifedipine versus fosinopril in uninephrectomized diabetic rats[].Kidney International.1992
